Skip to main content

Axitinib

Posterior reversible encephalopathy syndrome: case report

    Reactions Weekly volume 1935, page 101 (2022)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    USD 49.95

    Price excludes VAT (USA)
    Tax calculation will be finalised during checkout.

    Reference

    • Prasad A, et al. A Rare Case of Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Axitinib in Renal Cell Cancer. Annals of Neurology 92 (Suppl. 29): S175 abstr. S264, Oct 2022. Available from: URL: http://doi.org/10.1002/ana.26484 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Axitinib. Reactions Weekly 1935, 101 (2022). https://doi.org/10.1007/s40278-022-28896-z

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40278-022-28896-z